Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

Authors:
Taneja P; Maglic D; Kai F; Zhu S; Kendig RD and 2 more

Journal:
Clin Med Insights Oncol

Publication Year: 2010

PMCID:
PMC2883240

PMID:
20567632

View on PubMed View on PMC
Journal Information

Full Title: Clin Med Insights Oncol

Abbreviation: Clin Med Insights Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Characterization and Survival Benefit of Drug Approvals for Metastatic Prostate Cancer, 2004 to 202…
Benjamin DJ; Rezazadeh Kalebasty A. (2024) - Transparency Score: 3/6
Copper Chaperone for Superoxide Dismutase Subtypes as a Prognostic Marker in Luminal B Breast Cance…
Li Y; Du W; Yang R and 3 more (2024) - Transparency Score: 3/6
Peripheral Blood CD8<sup>+</sup> CD28<sup>+</sup> T Cells as an Independent Predictor of Treatment …
Wang S; Mu X; Wang X and 3 more (2024) - Transparency Score: 3/6
Prognostic Significance of the Cachexia Index in Patients with Non-Small-Cell Lung Cancer and Brain…
Xu H; Zhang B; Zhang Y and 5 more (2024) - Transparency Score: 3/6
Risk Factors for Distant Metastasis in T3 T4 Rectal Cancer.
Tang C; Xu J; Lin M and 5 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures: This manuscript has been read and approved by all authors. This paper is unique and is not under consideration by any other publication and has not been published elsewhere. The authors and peer reviewers of this paper report no conflicts of interest. The authors confirm that they have permission to reproduce any copyrighted material."

Evidence found in paper:

"We are grateful to K. Klein (Research Support Core, Wake Forest University Health Sciences) for editing the manuscript. K. Inoue is supported by ACS RSG-07-207-01-MGO, NIH/NCI 2R01CA106314–06, and P30CA12197. P. Taneja is supported by the Susan G. Komen Foundation postdoctoral fellowship KG080179."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025